Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SHE:301126)
China
· Delayed Price · Currency is CNY 10.74
+0.11 (1.03%)
At close: May 16, 2025, 2:57 PM CST
SHE:301126 Revenue
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd had revenue of 1.30B CNY in the quarter ending March 31, 2025, with 1.51% growth. This brings the company's revenue in the last twelve months to 5.25B, up 21.95% year-over-year. In the year 2024, Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd had annual revenue of 5.23B with 34.07% growth.
Revenue (ttm)
5.25B
Revenue Growth
+21.95%
P/S Ratio
0.43
Revenue / Employee
1.51M
Employees
3,461
Market Cap
2.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.23B | 1.33B | 34.07% |
| Dec 31, 2023 | 3.90B | 611.18M | 18.56% |
| Jan 1, 2023 | 3.29B | 700.15M | 27.01% |
| Dec 31, 2021 | 2.59B | 252.41M | 10.79% |
| Dec 31, 2020 | 2.34B | -116.76M | -4.75% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |